Huhtamaki PPL Q3 Review - One-Time Costs Dent Earnings; Expect Sequential Improvement: Systematix
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Systematix Research Report
Huhtamaki PPL Ltd.’s Q3 CY21 results were below our estimates with net revenue/Ebitda declines of 3%/60% YoY and negative profit after tax of Rs 218 million.
Lower capacity utilisation at the Thane plant (cost rationalisation and capacity shifting) likely impacted growth.
Gross margin (28%) remained under pressure as raw material prices continued to rise; we expect a recovery in one to two quarters based on moderation in biaxially oriented polypropylene films/biaxially-oriented polyethylene terephthalate prices by 14%/4% month-on-month in September 2021.
Huhtamaki PPL's Ebitda margin improved to 4.7% versus 3.4% QoQ due to lower employee costs.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.